ARSA and metachromatic leukodystrophy: To address the limitations regarding demyelination, an MLD mouse model was modified by using the transgenic ASA-null [tg/ASA-/-] mice, which overexpresses galactose-3-O-sulfotransferase-1 in myelinating cells.